GlassScriptPhysician profile
John W Barrington
NPI 1336120328
$2,195,432.84
in general payments reported to CMS, 2019-2025
20 companies · $313K in 2025
The $313K reported for 2025 was more than what 96% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $651K · 2020: $379K · 2021: $189K · 2022: $246K · 2023: $269K · 2024: $148K · 2025: $313K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $708K · Consulting Fee: $20K · Food and Beverage: $1,191 · Travel and Lodging: $744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $707,758.76 |
| Consulting Fee | $19,875.00 |
| Food and Beverage | $1,190.58 |
| Travel and Lodging | $743.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $667,231.77 | 2019-2025 | Arcos Revision Hip Instrumentation, Arcos, Mymobility Platform |
| Smith+Nephew, INC. | $608,106.69 | 2019-2025 | Journey II |
| Encore Medical, LP | $560,669.81 | 2019-2025 | Djo Surgical |
| Pacira Therapeutics, INC. | $306,318.97 | 2019-2021 | |
| Kyocera Medical Technologies, INC. | $27,967.09 | 2019-2023 | |
| Pacira Pharmaceuticals Incorporated | $17,096.78 | 2022-2024 | Iovera, Exparel, Zilretta |
| Alexion Pharmaceuticals, INC. | $4,080.00 | 2022 | |
| Medical Device Business Services, INC. | $2,750.00 | 2020 | |
| Shalby Advanced Technologies, INC. | $375.83 | 2023-2024 | Tahoe Uni Knee System, Tracone Uni Knee System |
| Maxx Orthopedics, INC. | $252.64 | 2021-2022 | |
| Vertex Pharmaceuticals Incorporated | $172.72 | 2025 | |
| Biotronik Nro, INC. | $128.95 | 2024 | Prospera |
| Depuy Synthes Sales INC. | $73.25 | 2020-2025 | Monovisc, Orthovisc |
| Orthalign INC | $73.19 | 2024 | Orthalign Plus |
| Ferring Pharmaceuticals INC. | $38.05 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $25.21 | 2025 | |
| Innovation Technologies INC | $21.37 | 2024 | Irrisept |
| Molnlycke Health Care US, LLC | $18.18 | 2024 | Mepilex Border Post-Op Ag, Avance |
| Bioventus LLC | $17.34 | 2025 | Exogen Ultrasound Bone Healing System |
| Theragen, INC. | $15.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Barrington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.